← FDA Drug Approvals (Drugs@FDA)

AMOXICILLIN AND CLAVULANATE POTASSIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: DEVA HOLDING AS · Approved 2023-11-29

Drug application

FDA Application #

ANDA210374

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMOXICILLIN AND CLAVULANATE POTASSIUM

Generic name

AMOXICILLIN AND CLAVULANATE POTASSIUM

Active ingredients

AMOXICILLIN; CLAVULANATE POTASSIUM

Dosage form

FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

DEVA HOLDING AS

Manufacturer

Devatis, Inc.

First approval

2023-11-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown